Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04211675
Title NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab (STING)
Acronym STING
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Nationwide Children's Hospital
Indications
Therapies
Age Groups: adult | child
Covered Countries USA


No variant requirements are available.